You are here

Eli Lilly

Amgen, Biohaven, Lilly and Teva plowed plenty into marketing migraine meds. Is it working?

Fierce Pharma

Mon, 11/22/21 - 10:21 am

pharma marketing

Teva Pharmaceutical

Eli Lilly, under pressure from Biohaven, launches head-to-head migraine trial between Emgality and Nurtec

Fierce Pharma

Thu, 11/18/21 - 11:03 pm

clinical trials

Could Eli Lilly Leapfrog Biogen in This Market?

Motley Fool

Wed, 11/17/21 - 10:26 am

Alzheimer's disease

Acelyrin raises $250M, licenses antibody drug that could rival Novartis, Lilly meds

MedCity News

Tue, 11/16/21 - 10:31 am

monoclonal antibodies

Boehringer-Lilly’s Jardiance obtains FDA priority review to treat heart failure

Pharmaceutical Business Review

Fri, 11/12/21 - 10:37 am

Boehringer Ingelheim

priority review

With $100M, startup to bring Lilly-licensed drug into trials

Bizjournals

Thu, 11/11/21 - 11:05 am

Acrivon Therapeutics

clinical trials

Eli Lilly touts long-term safety data for Olumiant amid classwide scrutiny on JAK meds

Fierce Pharma

Wed, 11/10/21 - 09:39 pm

Lilly pulls COVID-19 treatment from EU review while U.S. stocks up

Reuters

Wed, 11/3/21 - 11:46 pm

Judge rules HHS' letter enforcing 340B discounts was 'arbitrary'

Beckers Hospital Review

Tue, 11/2/21 - 11:51 pm

United Therapeutics

Eli Lilly serves up a win over Biden's HHS in drug discount court case

Endpoints

Mon, 11/1/21 - 11:02 pm

Eli Lilly and Pfizer Put Osteoarthritis Pain Drug Out of its Misery

BioSpace

Wed, 10/27/21 - 11:38 pm

As Lilly gears up for key 2022 launches, Trulicity, Taltz and more drive solid growth

Fierce Pharma

Tue, 10/26/21 - 11:54 pm

Eli Lilly kick-starts speedy FDA review for Alzheimer's hopeful donanemab—and a one-on-one test against Aduhelm

Fierce Biotech

Tue, 10/26/21 - 10:50 am

Alzheimer's disease

Will Merck's COVID-19 Pill Sink Regeneron's and Eli Lilly's Antibody Therapy Sales?

Motley Fool

Fri, 10/22/21 - 12:18 pm

Eli Lilly ordered to pay royalties on blockbuster diabetes drugs, though exact damages are unclear

Endpoints

Thu, 10/21/21 - 11:22 pm

Could This Be the Next Blockbuster Indication for Eli Lilly?

Motley Fool

Thu, 10/21/21 - 10:37 am

alopecia areata

clinical trials

Lilly's Longest Diabetes Drug Trial Lowers A1C and Increases Weight Loss

BioSpace

Tue, 10/19/21 - 11:53 am

clinical trials

Good news for Lilly as sintilimab hits the spot in lung cancer again

Pharmaforum

Tue, 10/19/21 - 10:47 am

non-squamous non-small cell lung cancer

non-small cell lung cancer

Regeneron, Novo Nordisk, Lilly and AbbVie stake claims on September's list of top TV ad spenders

Fierce Pharma

Mon, 10/18/21 - 10:49 pm

Eli Lilly's Verzenio snags first-in-class FDA approval for early breast cancer. But limited label poses a challenge

Fierce Pharma

Wed, 10/13/21 - 11:07 am

early breast cancer

Pages